14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $43.33 $53.35 Thursday, 2nd May 2024 BMY stock ended at $43.70. This is 1.15% less than the trading day before Wednesday, 1st May 2024. During the day the stock fluctuated 2.51% from a day low at $43.33 to a day high of $44.42.
90 days $43.33 $55.03
52 weeks $43.33 $69.10

Historical Bristol-Myers Squibb Company prices

Date Open High Low Close Volume
Sep 27, 2023 $58.58 $58.75 $57.61 $57.89 9 774 499
Sep 26, 2023 $58.87 $59.25 $58.52 $58.54 9 360 300
Sep 25, 2023 $58.84 $59.28 $58.55 $59.16 6 580 590
Sep 22, 2023 $59.33 $59.46 $58.77 $58.90 6 686 305
Sep 21, 2023 $58.56 $59.46 $58.54 $59.08 8 161 920
Sep 20, 2023 $58.80 $59.31 $58.71 $58.78 8 679 952
Sep 19, 2023 $58.56 $58.92 $58.34 $58.63 8 959 097
Sep 18, 2023 $59.04 $59.15 $58.33 $58.58 14 618 723
Sep 15, 2023 $59.44 $59.83 $58.86 $59.03 20 641 358
Sep 14, 2023 $60.14 $60.55 $59.28 $59.49 18 147 114
Sep 13, 2023 $60.25 $60.58 $59.65 $59.65 18 160 106
Sep 12, 2023 $61.01 $61.02 $59.84 $60.24 9 678 023
Sep 11, 2023 $60.75 $61.43 $60.68 $60.81 13 225 820
Sep 08, 2023 $60.16 $60.89 $60.01 $60.82 9 502 547
Sep 07, 2023 $59.87 $60.50 $59.86 $59.97 9 249 592
Sep 06, 2023 $60.30 $60.40 $59.46 $59.67 11 508 247
Sep 05, 2023 $61.89 $62.00 $60.59 $60.64 8 487 971
Sep 01, 2023 $61.83 $62.40 $61.83 $62.02 5 259 665
Aug 31, 2023 $62.45 $62.53 $61.65 $61.65 11 455 961
Aug 30, 2023 $62.93 $63.03 $62.20 $62.38 7 558 058
Aug 29, 2023 $61.98 $63.41 $61.98 $62.85 9 903 845
Aug 28, 2023 $62.06 $62.41 $61.38 $61.64 6 366 915
Aug 25, 2023 $61.42 $62.30 $61.25 $62.08 7 952 932
Aug 24, 2023 $61.36 $62.01 $61.23 $61.28 8 270 067
Aug 23, 2023 $62.26 $62.40 $61.41 $61.56 7 857 636
Click to get the best stock tips daily for free!

About Bristol-Myers Squibb Company

Bristol-Myers Squibb Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; Eliquis, an oral inhibitor for reduction in risk of stroke/systemic embolism in NVAF, and for th... BMY Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT